President & CFO Silvers Jason bought 2,000 shares at $16.00 on 2026-03-02; cluster of 3 other insiders buying within 14 days
Jason Silvers, President & CFO of Generate Biomedicines, executed 3 separate purchases totaling 2,000 shares for $32,000.00 at $16.00 per share on 2026-03-02. The stock is currently trading at $12.17, meaning the insider paid a blended average price of $16.00 above the current market price. This filing is notable for a cluster pattern: 3 other insiders also bought within the past 14 days, suggesting coordinated accumulation among multiple executives. The recent listing status (2 trading days) limits meaningful historical context for valuation assessment. The concentration of insider buying activity across multiple executives within a short timeframe may warrant investor attention to underlying business developments or market dynamics at the company.